Aripiprazole Intermedia CAS 129722-34-5;
Manufacturer Supple intermedia Aripiprazole Cum High puritate
Aripiprazole API CAS 129722-12-9
1-(2,3-Dichlorophenyl) piperazinum hydrochloridum CAS 119532-26-2
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 22246-18-0
7-(4-Bromobutoxy)-3,4-Dihydro-2(1H)-Quinolinone CAS 129722-34-5
| Nomen chemicum | 7-(4-Bromobutoxy)-3,4-Dihydro-2(1H)-Quinolinone |
| Synonyma | 7-(4-Bromobutoxy)-3,4-Dihydroquinolin-2(1H)-one;7-(4-Bromobutoxy) -1,2,3,4-Tetrahydro-2-Oxoquinoline;3,4-Dihydro-7-(4-Bromobutoxy)-2(1H)-Quinolinone;Aripiprazole immunditia 3 |
| CAS Number | 129722-34-5 |
| CATTUS Number | RF-PI2269 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C13H16BrNO2 |
| M. Pondus | 298.18 |
| Density | 1.383 g/cm3 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba aut pallide Yellow Crystal pulveris |
| Puritas / Analysis Methodus | >98.0% (HPLC) |
| Liquescens punctum | 110.0~114.0℃ |
| Damnum in Siccatio | <1.00% |
| Residere in Ignition | <0.50% |
| Metalla gravia (ut Pb) | ≤20ppm |
| Proton NMR Spectrum | Conformat ut Structure |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium Aripiprazole (CAS: 129722-12-9) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
7-(4-Bromobutoxy)-3,4-Dihydro-2(1H)-Quinolinone (CAS: 129722-34-5) medium est in synthesi Aripiprazolis (CAS: 129722-12-9).Degradatio facta in tabulis Aripiprazolis.Aripiprazole (Abilify).Novissima, longactingaripiprazola (quinolinone derivativa arylpiperazine), agonista partialis receptorum D2 esse videtur (id est receptores quosdam D2 excitat, dum alios in cerebro et concentratione medicamentorum locorum interclusit).Bioavailability Aripiprazolis circiter 87% est, cum summo plasmatis concentratio consecuta est ad 3 ad 5 horas postdosing.Metabolized est per siccitatem, hydroxylationem oxidativam, et N-dealkylationem, per CYPs 3A4 et 2D6 plurimum mediata.Ad curationem schizophreniae et perturbationes psychoticas pertinentes.A dopamine selectivo D2-receptor adversario cum dopamine autoreceptor agonist activitas.Antipsychotic.
